nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Prednisone—ankylosing spondylitis	0.131	0.186	CbGbCtD
Guanfacine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.104	0.149	CbGbCtD
Guanfacine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0817	0.116	CbGbCtD
Guanfacine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0791	0.113	CbGbCtD
Guanfacine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0679	0.0968	CbGbCtD
Guanfacine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0679	0.0968	CbGbCtD
Guanfacine—CYP3A4—Prednisolone—ankylosing spondylitis	0.067	0.0955	CbGbCtD
Guanfacine—CYP3A4—Prednisone—ankylosing spondylitis	0.0632	0.0902	CbGbCtD
Guanfacine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0395	0.0563	CbGbCtD
Guanfacine—Weight increased—Prednisone—ankylosing spondylitis	0.00111	0.0037	CcSEcCtD
Guanfacine—Vision blurred—Prednisolone—ankylosing spondylitis	0.0011	0.00368	CcSEcCtD
Guanfacine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00108	0.00363	CcSEcCtD
Guanfacine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00108	0.00362	CcSEcCtD
Guanfacine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00108	0.0036	CcSEcCtD
Guanfacine—Visual impairment—Betamethasone—ankylosing spondylitis	0.00108	0.0036	CcSEcCtD
Guanfacine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00107	0.00358	CcSEcCtD
Guanfacine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00106	0.00356	CcSEcCtD
Guanfacine—Malaise—Prednisolone—ankylosing spondylitis	0.00105	0.00352	CcSEcCtD
Guanfacine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00105	0.00351	CcSEcCtD
Guanfacine—Vertigo—Prednisolone—ankylosing spondylitis	0.00105	0.00351	CcSEcCtD
Guanfacine—Syncope—Prednisolone—ankylosing spondylitis	0.00104	0.0035	CcSEcCtD
Guanfacine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00104	0.0035	CcSEcCtD
Guanfacine—Eye disorder—Betamethasone—ankylosing spondylitis	0.00104	0.0035	CcSEcCtD
Guanfacine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00102	0.00343	CcSEcCtD
Guanfacine—Asthma—Methotrexate—ankylosing spondylitis	0.00102	0.0034	CcSEcCtD
Guanfacine—Convulsion—Prednisolone—ankylosing spondylitis	0.00101	0.00338	CcSEcCtD
Guanfacine—Hypertension—Prednisolone—ankylosing spondylitis	0.00101	0.00337	CcSEcCtD
Guanfacine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000994	0.00333	CcSEcCtD
Guanfacine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000992	0.00332	CcSEcCtD
Guanfacine—Bradycardia—Prednisone—ankylosing spondylitis	0.00099	0.00332	CcSEcCtD
Guanfacine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000987	0.00331	CcSEcCtD
Guanfacine—Alopecia—Betamethasone—ankylosing spondylitis	0.000987	0.00331	CcSEcCtD
Guanfacine—Discomfort—Prednisolone—ankylosing spondylitis	0.00098	0.00328	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000973	0.00326	CcSEcCtD
Guanfacine—Hallucination—Prednisone—ankylosing spondylitis	0.000968	0.00324	CcSEcCtD
Guanfacine—Malaise—Triamcinolone—ankylosing spondylitis	0.000966	0.00324	CcSEcCtD
Guanfacine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000964	0.00323	CcSEcCtD
Guanfacine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000963	0.00322	CcSEcCtD
Guanfacine—Syncope—Triamcinolone—ankylosing spondylitis	0.000961	0.00322	CcSEcCtD
Guanfacine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00096	0.00322	CcSEcCtD
Guanfacine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000959	0.00321	CcSEcCtD
Guanfacine—Oedema—Prednisolone—ankylosing spondylitis	0.000951	0.00318	CcSEcCtD
Guanfacine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000942	0.00315	CcSEcCtD
Guanfacine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00094	0.00315	CcSEcCtD
Guanfacine—Shock—Prednisolone—ankylosing spondylitis	0.000935	0.00313	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000935	0.00313	CcSEcCtD
Guanfacine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000928	0.00311	CcSEcCtD
Guanfacine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000928	0.00311	CcSEcCtD
Guanfacine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000926	0.0031	CcSEcCtD
Guanfacine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000925	0.0031	CcSEcCtD
Guanfacine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000923	0.00309	CcSEcCtD
Guanfacine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000919	0.00308	CcSEcCtD
Guanfacine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000912	0.00306	CcSEcCtD
Guanfacine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00091	0.00305	CcSEcCtD
Guanfacine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00091	0.00305	CcSEcCtD
Guanfacine—Eye disorder—Prednisone—ankylosing spondylitis	0.000909	0.00304	CcSEcCtD
Guanfacine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000907	0.00304	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000905	0.00303	CcSEcCtD
Guanfacine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000902	0.00302	CcSEcCtD
Guanfacine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000902	0.00302	CcSEcCtD
Guanfacine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000901	0.00302	CcSEcCtD
Guanfacine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000899	0.00301	CcSEcCtD
Guanfacine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000892	0.00299	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00088	0.00295	CcSEcCtD
Guanfacine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00088	0.00295	CcSEcCtD
Guanfacine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000878	0.00294	CcSEcCtD
Guanfacine—Malaise—Betamethasone—ankylosing spondylitis	0.000877	0.00294	CcSEcCtD
Guanfacine—Malaise—Dexamethasone—ankylosing spondylitis	0.000877	0.00294	CcSEcCtD
Guanfacine—Oedema—Triamcinolone—ankylosing spondylitis	0.000874	0.00293	CcSEcCtD
Guanfacine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000873	0.00293	CcSEcCtD
Guanfacine—Vertigo—Betamethasone—ankylosing spondylitis	0.000873	0.00293	CcSEcCtD
Guanfacine—Syncope—Betamethasone—ankylosing spondylitis	0.000872	0.00292	CcSEcCtD
Guanfacine—Syncope—Dexamethasone—ankylosing spondylitis	0.000872	0.00292	CcSEcCtD
Guanfacine—Sweating—Methotrexate—ankylosing spondylitis	0.000868	0.00291	CcSEcCtD
Guanfacine—Shock—Triamcinolone—ankylosing spondylitis	0.00086	0.00288	CcSEcCtD
Guanfacine—Insomnia—Prednisolone—ankylosing spondylitis	0.00086	0.00288	CcSEcCtD
Guanfacine—Alopecia—Prednisone—ankylosing spondylitis	0.000859	0.00288	CcSEcCtD
Guanfacine—Shock—Methylprednisolone—ankylosing spondylitis	0.000858	0.00288	CcSEcCtD
Guanfacine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000854	0.00286	CcSEcCtD
Guanfacine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000854	0.00286	CcSEcCtD
Guanfacine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000854	0.00286	CcSEcCtD
Guanfacine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000853	0.00286	CcSEcCtD
Guanfacine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000852	0.00285	CcSEcCtD
Guanfacine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000845	0.00283	CcSEcCtD
Guanfacine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000843	0.00283	CcSEcCtD
Guanfacine—Convulsion—Betamethasone—ankylosing spondylitis	0.000842	0.00282	CcSEcCtD
Guanfacine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000842	0.00282	CcSEcCtD
Guanfacine—Hypertension—Betamethasone—ankylosing spondylitis	0.000839	0.00281	CcSEcCtD
Guanfacine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000839	0.00281	CcSEcCtD
Guanfacine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000828	0.00277	CcSEcCtD
Guanfacine—Myalgia—Betamethasone—ankylosing spondylitis	0.000828	0.00277	CcSEcCtD
Guanfacine—Anxiety—Betamethasone—ankylosing spondylitis	0.000825	0.00276	CcSEcCtD
Guanfacine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000825	0.00276	CcSEcCtD
Guanfacine—Discomfort—Betamethasone—ankylosing spondylitis	0.000818	0.00274	CcSEcCtD
Guanfacine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000818	0.00274	CcSEcCtD
Guanfacine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000815	0.00273	CcSEcCtD
Guanfacine—Vision blurred—Prednisone—ankylosing spondylitis	0.000798	0.00267	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000797	0.00267	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000795	0.00266	CcSEcCtD
Guanfacine—Oedema—Dexamethasone—ankylosing spondylitis	0.000793	0.00266	CcSEcCtD
Guanfacine—Oedema—Betamethasone—ankylosing spondylitis	0.000793	0.00266	CcSEcCtD
Guanfacine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000791	0.00265	CcSEcCtD
Guanfacine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000789	0.00264	CcSEcCtD
Guanfacine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000786	0.00263	CcSEcCtD
Guanfacine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000785	0.00263	CcSEcCtD
Guanfacine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000784	0.00262	CcSEcCtD
Guanfacine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000783	0.00262	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000783	0.00262	CcSEcCtD
Guanfacine—Shock—Betamethasone—ankylosing spondylitis	0.000781	0.00261	CcSEcCtD
Guanfacine—Shock—Dexamethasone—ankylosing spondylitis	0.000781	0.00261	CcSEcCtD
Guanfacine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00078	0.00261	CcSEcCtD
Guanfacine—Agitation—Prednisone—ankylosing spondylitis	0.000778	0.00261	CcSEcCtD
Guanfacine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000774	0.00259	CcSEcCtD
Guanfacine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000774	0.00259	CcSEcCtD
Guanfacine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00077	0.00258	CcSEcCtD
Guanfacine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000768	0.00257	CcSEcCtD
Guanfacine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000767	0.00257	CcSEcCtD
Guanfacine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000767	0.00257	CcSEcCtD
Guanfacine—Malaise—Prednisone—ankylosing spondylitis	0.000763	0.00256	CcSEcCtD
Guanfacine—Vertigo—Prednisone—ankylosing spondylitis	0.000761	0.00255	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00076	0.00254	CcSEcCtD
Guanfacine—Syncope—Prednisone—ankylosing spondylitis	0.000759	0.00254	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000758	0.00254	CcSEcCtD
Guanfacine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000754	0.00253	CcSEcCtD
Guanfacine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000752	0.00252	CcSEcCtD
Guanfacine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000744	0.00249	CcSEcCtD
Guanfacine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000741	0.00248	CcSEcCtD
Guanfacine—Hypotension—Betamethasone—ankylosing spondylitis	0.000741	0.00248	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000734	0.00246	CcSEcCtD
Guanfacine—Convulsion—Prednisone—ankylosing spondylitis	0.000734	0.00246	CcSEcCtD
Guanfacine—Hypertension—Prednisone—ankylosing spondylitis	0.000731	0.00245	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000723	0.00242	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000723	0.00242	CcSEcCtD
Guanfacine—Myalgia—Prednisone—ankylosing spondylitis	0.000721	0.00241	CcSEcCtD
Guanfacine—Arthralgia—Prednisone—ankylosing spondylitis	0.000721	0.00241	CcSEcCtD
Guanfacine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000721	0.00241	CcSEcCtD
Guanfacine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000719	0.00241	CcSEcCtD
Guanfacine—Anxiety—Prednisone—ankylosing spondylitis	0.000718	0.00241	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—ankylosing spondylitis	0.000718	0.00241	CcSEcCtD
Guanfacine—Insomnia—Betamethasone—ankylosing spondylitis	0.000718	0.0024	CcSEcCtD
Guanfacine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000718	0.0024	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000713	0.00239	CcSEcCtD
Guanfacine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000712	0.00239	CcSEcCtD
Guanfacine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000712	0.00239	CcSEcCtD
Guanfacine—Discomfort—Prednisone—ankylosing spondylitis	0.000712	0.00239	CcSEcCtD
Guanfacine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000701	0.00235	CcSEcCtD
Guanfacine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000698	0.00234	CcSEcCtD
Guanfacine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000698	0.00234	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000693	0.00232	CcSEcCtD
Guanfacine—Oedema—Prednisone—ankylosing spondylitis	0.000691	0.00231	CcSEcCtD
Guanfacine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00069	0.00231	CcSEcCtD
Guanfacine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00069	0.00231	CcSEcCtD
Guanfacine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00069	0.00231	CcSEcCtD
Guanfacine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000684	0.00229	CcSEcCtD
Guanfacine—Fatigue—Betamethasone—ankylosing spondylitis	0.000684	0.00229	CcSEcCtD
Guanfacine—Shock—Prednisone—ankylosing spondylitis	0.00068	0.00228	CcSEcCtD
Guanfacine—Tachycardia—Prednisone—ankylosing spondylitis	0.000674	0.00226	CcSEcCtD
Guanfacine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000668	0.00224	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000667	0.00223	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000656	0.0022	CcSEcCtD
Guanfacine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000654	0.00219	CcSEcCtD
Guanfacine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000654	0.00219	CcSEcCtD
Guanfacine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000649	0.00217	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000649	0.00217	CcSEcCtD
Guanfacine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000644	0.00216	CcSEcCtD
Guanfacine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000643	0.00215	CcSEcCtD
Guanfacine—Malaise—Methotrexate—ankylosing spondylitis	0.000638	0.00214	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—ankylosing spondylitis	0.000636	0.00213	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00063	0.00211	CcSEcCtD
Guanfacine—Dizziness—Prednisolone—ankylosing spondylitis	0.000629	0.00211	CcSEcCtD
Guanfacine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000627	0.0021	CcSEcCtD
Guanfacine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000627	0.0021	CcSEcCtD
Guanfacine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000627	0.0021	CcSEcCtD
Guanfacine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000626	0.0021	CcSEcCtD
Guanfacine—Insomnia—Prednisone—ankylosing spondylitis	0.000625	0.00209	CcSEcCtD
Guanfacine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00062	0.00208	CcSEcCtD
Guanfacine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000619	0.00207	CcSEcCtD
Guanfacine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000617	0.00207	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—ankylosing spondylitis	0.000613	0.00205	CcSEcCtD
Guanfacine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000608	0.00204	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—ankylosing spondylitis	0.000602	0.00202	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—ankylosing spondylitis	0.000602	0.00202	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000602	0.00202	CcSEcCtD
Guanfacine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000601	0.00201	CcSEcCtD
Guanfacine—Rash—Prednisolone—ankylosing spondylitis	0.0006	0.00201	CcSEcCtD
Guanfacine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000599	0.00201	CcSEcCtD
Guanfacine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000597	0.002	CcSEcCtD
Guanfacine—Fatigue—Prednisone—ankylosing spondylitis	0.000596	0.002	CcSEcCtD
Guanfacine—Headache—Prednisolone—ankylosing spondylitis	0.000596	0.002	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—ankylosing spondylitis	0.000595	0.00199	CcSEcCtD
Guanfacine—Constipation—Prednisone—ankylosing spondylitis	0.000591	0.00198	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—ankylosing spondylitis	0.000582	0.00195	CcSEcCtD
Guanfacine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000578	0.00194	CcSEcCtD
Guanfacine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000577	0.00193	CcSEcCtD
Guanfacine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000569	0.00191	CcSEcCtD
Guanfacine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000569	0.00191	CcSEcCtD
Guanfacine—Asthenia—Betamethasone—ankylosing spondylitis	0.000569	0.00191	CcSEcCtD
Guanfacine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000565	0.00189	CcSEcCtD
Guanfacine—Nausea—Prednisolone—ankylosing spondylitis	0.000565	0.00189	CcSEcCtD
Guanfacine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000561	0.00188	CcSEcCtD
Guanfacine—Pruritus—Betamethasone—ankylosing spondylitis	0.000561	0.00188	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000558	0.00187	CcSEcCtD
Guanfacine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000556	0.00186	CcSEcCtD
Guanfacine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000555	0.00186	CcSEcCtD
Guanfacine—Rash—Triamcinolone—ankylosing spondylitis	0.000551	0.00185	CcSEcCtD
Guanfacine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000551	0.00185	CcSEcCtD
Guanfacine—Rash—Methylprednisolone—ankylosing spondylitis	0.00055	0.00184	CcSEcCtD
Guanfacine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00055	0.00184	CcSEcCtD
Guanfacine—Headache—Triamcinolone—ankylosing spondylitis	0.000548	0.00183	CcSEcCtD
Guanfacine—Headache—Methylprednisolone—ankylosing spondylitis	0.000547	0.00183	CcSEcCtD
Guanfacine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000546	0.00183	CcSEcCtD
Guanfacine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000543	0.00182	CcSEcCtD
Guanfacine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000543	0.00182	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—ankylosing spondylitis	0.00054	0.00181	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000526	0.00176	CcSEcCtD
Guanfacine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000525	0.00176	CcSEcCtD
Guanfacine—Dizziness—Betamethasone—ankylosing spondylitis	0.000525	0.00176	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—ankylosing spondylitis	0.000522	0.00175	CcSEcCtD
Guanfacine—Nausea—Triamcinolone—ankylosing spondylitis	0.000519	0.00174	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000519	0.00174	CcSEcCtD
Guanfacine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000518	0.00174	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000515	0.00172	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—ankylosing spondylitis	0.000513	0.00172	CcSEcCtD
Guanfacine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000509	0.00171	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000508	0.0017	CcSEcCtD
Guanfacine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000504	0.00169	CcSEcCtD
Guanfacine—Vomiting—Betamethasone—ankylosing spondylitis	0.000504	0.00169	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000502	0.00168	CcSEcCtD
Guanfacine—Rash—Betamethasone—ankylosing spondylitis	0.0005	0.00168	CcSEcCtD
Guanfacine—Rash—Dexamethasone—ankylosing spondylitis	0.0005	0.00168	CcSEcCtD
Guanfacine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0005	0.00167	CcSEcCtD
Guanfacine—Dermatitis—Betamethasone—ankylosing spondylitis	0.0005	0.00167	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—ankylosing spondylitis	0.000498	0.00167	CcSEcCtD
Guanfacine—Headache—Dexamethasone—ankylosing spondylitis	0.000497	0.00166	CcSEcCtD
Guanfacine—Headache—Betamethasone—ankylosing spondylitis	0.000497	0.00166	CcSEcCtD
Guanfacine—Asthenia—Prednisone—ankylosing spondylitis	0.000496	0.00166	CcSEcCtD
Guanfacine—Pruritus—Prednisone—ankylosing spondylitis	0.000489	0.00164	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000476	0.00159	CcSEcCtD
Guanfacine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000473	0.00158	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000472	0.00158	CcSEcCtD
Guanfacine—Nausea—Dexamethasone—ankylosing spondylitis	0.000471	0.00158	CcSEcCtD
Guanfacine—Nausea—Betamethasone—ankylosing spondylitis	0.000471	0.00158	CcSEcCtD
Guanfacine—Dizziness—Prednisone—ankylosing spondylitis	0.000457	0.00153	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000456	0.00153	CcSEcCtD
Guanfacine—Vomiting—Prednisone—ankylosing spondylitis	0.000439	0.00147	CcSEcCtD
Guanfacine—Rash—Prednisone—ankylosing spondylitis	0.000436	0.00146	CcSEcCtD
Guanfacine—Dermatitis—Prednisone—ankylosing spondylitis	0.000435	0.00146	CcSEcCtD
Guanfacine—Headache—Prednisone—ankylosing spondylitis	0.000433	0.00145	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000425	0.00143	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—ankylosing spondylitis	0.000414	0.00139	CcSEcCtD
Guanfacine—Nausea—Prednisone—ankylosing spondylitis	0.00041	0.00137	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—ankylosing spondylitis	0.000409	0.00137	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000395	0.00132	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—ankylosing spondylitis	0.000382	0.00128	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—ankylosing spondylitis	0.000367	0.00123	CcSEcCtD
Guanfacine—Rash—Methotrexate—ankylosing spondylitis	0.000364	0.00122	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000364	0.00122	CcSEcCtD
Guanfacine—Headache—Methotrexate—ankylosing spondylitis	0.000362	0.00121	CcSEcCtD
Guanfacine—Nausea—Methotrexate—ankylosing spondylitis	0.000343	0.00115	CcSEcCtD
